Normalized Income after Taxes: A company's after tax profit or loss smoothed out by elimination of all non-recurring items.
China SXT Pharmaceuticals, Inc. (SXTC) Normalized Income after Taxes data is not available.
| Income Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Normalized Income after Taxes |
-- |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Balance Sheet Financials | |
$26.04M |
|
$0.15M |
|
$0.31M |
|
$26.35M |
|
$5.96M |
|
$0.07M |
|
$0.16M |
|
$6.12M |
|
$20.23M |
|
$20.23M |
|
$20.23M |
|
116.03M |
|
| Cash Flow Statement Financials | |
$-1.75M |
|
$-0.92M |
|
$5.37M |
|
$18.13M |
|
$21.20M |
|
$3.07M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|